abstract |
The present invention relates to pharmaceutical compositions and more particularly to a pharmaceutical composition containing {1S- [1a, 2a, 3ß (1S *, 2R *), 5ß]} -3- (7 - {[2- (3, 4-difluorophenyl) cycloprop yl] amino} -5- (propylthio) -3H-1,2,3-triazolo [4,5-d] pyrimidin-3-yl) -5 - (2-hydroxyethoxy) cyclopentan-1, 2-diol |